Whether contributing intellectual or financial resources, TEDCO qualifies concepts, management teams, and the potential market value of entrepreneurial innovation by supporting the enterprises with the greatest potential for success. Through this approach TEDCO has acquired an impressive portfolio of companies with equally impressive success stories. The following are select companies from our portfolio.

Portfolio News

Find out about recent developments with our portfolio companies.

News article

TEDCO Portfolio Company, Adaptive Phage Therpeutics' CEO, Greg Merrill, speaks on NPR

Enter a new treatment called 'phage therapy' and Greg Merril, CEO and co-founder of Adaptive Phage
read now
News article

Linshom Announces FDA Clearance of the Linshom Respiratory Monitoring Device (LRMD)

Linshom announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s
read now
News article

Theraly Fibrosis, a TEDCO portfolio company, awarded $3.9 Million SBIR Phase II grant to support the development of TLY012 for Chronic Pancreatitis

Theraly Fibrosis, a preclinical-stage biotechnology company focused on development and
read now